Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1

  1. Eron, J.J.
  2. Orkin, C.
  3. Cunningham, D.
  4. Pulido, F.
  5. Post, F.A.
  6. De Wit, S.
  7. Lathouwers, E.
  8. Hufkens, V.
  9. Jezorwski, J.
  10. Petrovic, R.
  11. Brown, K.
  12. Van Landuyt, E.
  13. Opsomer, M.
  14. De Wit, S.
  15. Florence, E.
  16. Moutschen, M.
  17. Van Wijngaerden, E.
  18. Vandekerckhove, L.
  19. Vandercam, B.
  20. Brunetta, J.
  21. Conway, B.
  22. Klein, M.
  23. Murphy, D.
  24. Rachlis, A.
  25. Shafran, S.
  26. Walmsley, S.
  27. Ajana, F.
  28. Cotte, L.
  29. Girardy, P.-M.
  30. Katlama, C.
  31. Molina, J.-M.
  32. Poizot-Martin, I.
  33. Raffi, F.
  34. Rey, D.
  35. Reynes, J.
  36. Teicher, E.
  37. Yazdanpanah, Y.
  38. Gasiorowski, J.
  39. Halota, W.
  40. Horban, A.
  41. Piekarska, A.
  42. Witor, A.
  43. Arribas, J.R.
  44. Perez-Valero, I.
  45. Berenguer, J.
  46. Casado, J.
  47. Gatell, J.M.
  48. Gutierrez, F.
  49. Galindo, M.J.
  50. Gutierrez, M.D.M.
  51. Iribarren, J.A.
  52. Knobel, H.
  53. Negredo, E.
  54. Pineda, J.A.
  55. Podzamczer, D.
  56. Sogorb, J.P.
  57. Pulido, F.
  58. Ricart, C.
  59. Rivero, A.
  60. Santos Gil, I.
  61. Blaxhult, A.
  62. Flamholc, L.
  63. Gisslèn, M.
  64. Thalme, A.
  65. Fehr, J.
  66. Rauch, A.
  67. Stoeckle, M.
  68. Clarke, A.
  69. Gazzard, B.G.
  70. Johnson, M.A.
  71. Orkin, C.
  72. Ustianowski, A.
  73. Waters, L.
  74. Bailey, J.
  75. Benson, P.
  76. Bhatti, L.
  77. Brar, I.
  78. Bredeek, U.F.
  79. Brinson, C.
  80. Crofoot, G.
  81. Cunningham, D.
  82. DeJesus, E.
  83. Dietz, C.
  84. Dretler, R.
  85. Eron, J.
  86. Felizarta, F.
  87. Fichtenbaum, C.
  88. Gallant, J.
  89. Gathe, J.
  90. Hagins, D.
  91. Henn, S.
  92. Henry, W.K.
  93. Huhn, G.
  94. Jain, M.
  95. Lucasti, C.
  96. Martorell, C.
  97. McDonald, C.
  98. Mills, A.
  99. Morales-Ramirez, J.
  100. Mounzer, K.
  101. Nahass, R.
  102. Olivet, H.
  103. Osiyemi, O.
  104. Prelutsky, D.
  105. Ramgopal, M.
  106. Rashbaum, B.
  107. Richmond, G.
  108. Ruane, P.
  109. Scarsella, A.
  110. Scribner, A.
  111. Shalit, P.
  112. Shamblaw, D.
  113. Slim, J.
  114. Tashima, K.
  115. Voskuhl, G.
  116. Ward, D.
  117. Wilkin, A.
  118. de Vente, J.
  119. Mostrar todos los/as autores/as +
Revista:
Antiviral Research

ISSN: 1872-9096 0166-3542

Año de publicación: 2019

Volumen: 170

Tipo: Artículo

DOI: 10.1016/J.ANTIVIRAL.2019.104543 GOOGLE SCHOLAR lock_openAcceso abierto editor

Objetivos de desarrollo sostenible